Pale Fire Capital SE Grows Holdings in Liquidia Corporation $LQDA

Pale Fire Capital SE increased its holdings in Liquidia Corporation (NASDAQ:LQDA) by 2.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 388,377 shares of the company’s stock after acquiring an additional 8,985 shares during the quarter. Liquidia comprises about 1.2% of Pale Fire Capital SE’s investment portfolio, making the stock its 14th biggest holding. Pale Fire Capital SE’s holdings in Liquidia were worth $14,657,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. purchased a new stake in Liquidia in the fourth quarter worth about $25,000. NewEdge Advisors LLC bought a new position in shares of Liquidia during the second quarter valued at approximately $25,000. Covestor Ltd lifted its holdings in shares of Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after purchasing an additional 359 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Liquidia by 281.2% during the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after purchasing an additional 4,927 shares during the last quarter. Finally, Hurley Capital LLC boosted its position in shares of Liquidia by 140.7% in the 4th quarter. Hurley Capital LLC now owns 5,200 shares of the company’s stock worth $179,000 after purchasing an additional 3,040 shares in the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Liquidia

In other news, Director Paul B. Manning sold 200,000 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $63.91, for a total value of $12,782,000.00. Following the completion of the transaction, the director owned 716,311 shares in the company, valued at $45,779,436.01. The trade was a 21.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen M. Bloch sold 318,893 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $50.23, for a total value of $16,017,995.39. Following the completion of the transaction, the director owned 1,870,042 shares of the company’s stock, valued at $93,932,209.66. This represents a 14.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 2,022,134 shares of company stock worth $129,579,224 over the last ninety days. 25.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on LQDA. Oppenheimer set a $75.00 price target on Liquidia in a research note on Friday, June 5th. Piper Sandler set a $129.00 target price on Liquidia in a report on Friday. Wells Fargo & Company increased their target price on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Needham & Company LLC raised their price target on Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Raymond James Financial restated a “strong-buy” rating and set a $68.00 price target on shares of Liquidia in a report on Thursday, June 4th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $86.18.

Liquidia Trading Down 3.2%

Shares of NASDAQ LQDA opened at $86.22 on Friday. The firm’s 50 day moving average price is $71.22 and its 200-day moving average price is $50.08. Liquidia Corporation has a 52-week low of $16.82 and a 52-week high of $91.10. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The company has a market cap of $7.67 billion, a PE ratio of 615.90 and a beta of 0.55.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.11. The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business’s revenue for the quarter was up 4187.1% compared to the same quarter last year. On average, equities research analysts expect that Liquidia Corporation will post 3.02 EPS for the current fiscal year.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).